News Release

Contacts:

Integra LifeSciences Holdings Corporation

John B. Henneman, III                   Maria Platsis
Executive Vice President                Senior Director of Corporate Development
Chief Administrative Officer            and Investor Relations
(609) 936-2481                          (609) 936-2333
jhenneman@Integra-LS.com                mplatsis@Integra-LS.com


                  Integra LifeSciences Names Maureen Bellantoni
                             Chief Financial Officer


Plainsboro, New Jersey / January 10, 2006 / -- Integra LifeSciences Holdings
Corporation (NASDAQ: IART) announced today that Maureen Blanchfield Bellantoni
will join the Company as Executive Vice President and Chief Financial Officer,
effective immediately. Ms. Bellantoni joins Integra with more than twenty years
experience in finance, accounting and operations.

"We are delighted that Maureen has agreed to join Integra," said Stuart M.
Essig, Integra's President and Chief Executive Officer, who is speaking at the
24th Annual JPMorgan Healthcare Conference. "Maureen will be focusing on all
aspects of our financial organization. I look forward to working closely with
Maureen as together we continue to build Integra through internal development
and strategic acquisitions."


"Maureen brings with her a diverse background of experience which we expect to
significantly strengthen our management team," said Keith Bradley, Chairman of
Integra's Audit Committee. "With her strong financial and operations background,
she will be a valuable asset to our Company as we continue to pursue our
expansion strategy."

"Integra's commitment to growth and profitability in the medical technology
industry is extremely impressive," said Ms. Bellantoni. "I am pleased to have
the opportunity to make a contribution to Integra's success at such an important
stage of its development."

David Holtz, currently Senior Vice President, Finance, will maintain his role of
principal accounting officer as well as assume responsibility for worldwide
shared services and planning and will report to Ms. Bellantoni. In this expanded
role, Mr. Holtz will utilize his experience in planning and reporting to unify
this critical worldwide function and to ensure that Integra's standards are
directly aligned and support the Company's strategy.

Ms. Bellantoni has extensive experience in both finance and operations. She most
recently served as Senior Vice President and Chief Financial Officer of CP
Kelco, a global leader in the hydrocolloids market from 2003 through its sale to
J.M. Huber. The business was owned by Lehman Brothers and J.M. Huber. From 2000
to 2002 Maureen served as Chief Financial Officer North America and Senior Vice
President of Finance of Burger King where she managed the worldwide finance
organization enabling the company to execute its business turnaround plan and
its separation from parent company Diageo, plc. During 1999 to 2000 she served
as Executive Vice President Finance for Rohn Industries Inc., a publicly traded
telecommunications company.




From 1993 to 1998 she served at Sara Lee Corporation as President and Chief
Operating Officer for their Bil Mar Foods division, Vice President, Finance and
Chief Financial Officer for Sara Lee Meats, and Vice President, Finance and
Chief Financial Officer for PYA/Monarch, Inc. At Sara Lee, Ms. Bellantoni
oversaw division CFOs throughout the United States, Mexico and Europe, and was
responsible for implementing rapid growth for her divisions, including designing
aggressive growth plans and coordinating worldwide business and operational
strategies.

From 1985 to 1993 Ms. Bellantoni was with Emerson Electric Company, as Vice
President, Finance and Chief Financial Officer for their Automatic Switch
Division and Vice President, Far East and Vice President, Finance and Chief
Financial Officer for the Branson Ultrasonics Corporation.

From 1996 to 2000 she served as a Member of the Board of Directors, Audit
Committee, and Compensation Committee of Michael Foods, Inc. Ms. Bellantoni
received a Bachelor of Science Degree from the University of Bridgeport and a
Master of Business Administration from the University of Connecticut.

Integra LifeSciences Holdings Corporation is a diversified medical technology
company that develops, manufactures, and markets medical devices for use in a
variety of applications. The primary applications for our products are
neurosurgery, reconstructive surgery and general surgery. Integra is a leader in
applying the principles of biotechnology to medical devices that improve
patients' quality of life. Our corporate headquarters are in Plainsboro, New
Jersey, and we have manufacturing and research facilities located throughout the
world. We have approximately 1,300 employees. Please visit our website at
(http://www.Integra-LS.com).

This news release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual results to
differ materially from predicted or expected results. The economic, competitive,
governmental, technological and other factors identified under the heading
"Factors That May Affect Our Future Performance" included in the Business
section of Integra's Annual Report on Form 10-K for the year ended December 31,
2004 and information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results.


Source: Integra LifeSciences Holdings Corporation